Remove directory food-and-drug-administration-fda
article thumbnail

FDA Introduces Dietary Supplement Ingredient Directory

Health Law Advisor

Food and Drug Administration (“FDA”) announced the launch of its new Dietary Supplement Ingredient Directory (the “Directory”), which the agency describes as “a one stop shop of ingredient information that was previously found on different FDA webpages.”

FDA 52
article thumbnail

Connected Medical Devices—the Next Target for Ransomware Attacks

Healthcare IT Today

Food and Drug Administration (FDA) has recognized the problem and issued multiple guidance documents over the years—as recently as this March —to ensure the cybersecurity of medical devices. Although none of the FDA recommendations are legally enforceable, device manufacturers no longer have a choice but to comply.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News – July 29, 2022

Hall Render

HHS proposes reinstating nondiscrimination protections stripped by Trump administration. State launches new online directory to find behavioral health specialists in Colorado. Hospitals push for PHE extension into 2023. Patients want greater control over health data sharing, AMA survey shows. Traveling nurse wages take a fall.

article thumbnail

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

Notably, the Act neither fulfilled the Biden Administration’s request for additional COVID-19 response funding nor included the Verifying Accurate Leading-edge In Vitro Clinical Test (IVCT) Development (VALID) Act, which proposed updating the current diagnostic testing regulatory framework. 117-164 ) (the “Act”)—an approximately $1.7

Medicaid 104
article thumbnail

GOP House Opens With Abortion Agenda

Kaiser Health News

On one hand, the FDA has relaxed some of the risk evaluation and mitigation strategies (REMS) from the prescribing rules surrounding abortion pills. On one hand, the FDA has relaxed some of the risk evaluation and mitigation strategies (REMS) from the prescribing rules surrounding abortion pills. Cathy McMorris Rodgers (R-Wash.)